BAD HOMBURG, Germany , May 5, 2026 /PRNewswire/ -- "Fresenius Medical Care delivered continued operational and financial progress in the first quarter, with organic revenue growth, improved profitability...
Barchart Research What to Expect from FMS Earnings FMS Generated May 4, 2026 Current Price $22.65 EPS Estimate $$0.59 Consensus Rating Hold Average Move 4.55% Fresenius Medical Care's Profitability Streak...
/DaVita%20Inc%20sign%20on%20building-by%20photo-denver%20via%20Shutterstock.jpg)
DaVita has outperformed the Health Care sector recently, but analysts are cautious about the stock’s prospects.
BAD HOMBURG, Germany , Feb. 24, 2026 /PRNewswire/ -- "Fresenius Medical Care closed a milestone year marked by outstanding profitability gains. Over the past three years, we built a stronger and...
BAD HOMBURG, Germany , Jan. 9, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal disease, will accelerate its share...
BAD HOMBURG, Germany , Dec. 10, 2025 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal disease, has...
BAD HOMBURG, Germany , Nov. 4, 2025 /PRNewswire/ -- "In Q3 of 2025, we continued the momentum and further accelerated revenue growth. Conversion into operating income 2 growth increased as...
BAD HOMBURG, Germany , Oct. 30, 2025 /PRNewswire/ -- Fresenius Medical Care AG (FME), the world's leading provider of products and services for people with kidney diseases, will present new research...
Bank of America Securities analyst Marianne Bulot downgraded Fresenius Medical Care to a Sell today and set a price target of $22.00. The company’s shares opened today at $26.70.Elevate Your Investing...
Fresenius Medical Care AG & Co. KGaA received a Sell rating and a €38.00 price target from Bank of America Securities analyst Anna Ractliffe today. The company’s shares closed yesterday at €47.55.Elevate...